Genzyme slides on FDA woes; Salix soars
March 25, 2010 at 09:34 AM EDT
Genzyme Corp. shares slide for the second day in early activity on news that it might have to pay substantial penalties to the U.S. government for quality-control deficiencies at a key manufacturing facility.
